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Tropheryma whipplei, which causes Whipple disease, 
is found in human feces and may cause gastroenteritis. To 
show that T. whipplei causes gastroenteritis, PCRs for T. 
whipplei were conducted with feces from children 2–4 years 
of age. Western blotting was performed for samples from 
children with diarrhea who had positive or negative results 
for T. whipplei. T. whipplei was found in samples from 36 
(15%) of 241 children with gastroenteritis and associated 
with other diarrheal pathogens in 13 (33%) of 36. No posi-
tive specimen was detected for controls of the same age 
(0/47; p = 0.008). Bacterial loads in case-patients were as 
high as those in patients with Whipple disease and sig-
niﬁ  cantly higher than those in adult asymptomatic carriers 
(p = 0.002). High incidence in patients and evidence of clon-
al circulation suggests that some cases of gastroenteritis 
are caused or exacerbated by T. whipplei, which may be 
co-transmitted with other intestinal pathogens.
F
or decades, Whipple disease was considered to be a 
metabolic disorder in humans (1). An accumulation of 
data, such as antimicrobial drug susceptibilities and obser-
vation of atypical bacteria in intestinal macrophages, has 
suggested that this disease is an infectious disease. Tro-
pheryma whipplei is recognized as the infectious agent 
responsible for Whipple disease (2). Recent studies using 
molecular biology (3–5) and culture-dependent (6–10) 
techniques have enabled the T. whipplei genome to be fully 
sequenced (11,12) and have resulted in development of 
new culture media (13), selection of highly sensitive prim-
ers for quantitative PCR (14), and genotyping (15–19). The 
bacterium is found in a viable form in stools of infected 
patients (9).
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Until recently, T. whipplei was considered a rare bac-
terium that caused an uncommon disease (2). However, re-
cent studies have conﬁ  rmed that T. whipplei is common in 
stool samples (20,21). T. whipplei DNA has been detected 
in sewage and is highly prevalent in the feces of sewer 
workers (12%–26%) (1,20,22–25). Moreover, the preva-
lence of T. whipplei in feces of healthy children 2–10 years 
of age who lived in rural Senegal (sub-Saharan Africa) was 
44% (46/105) (21). These data, together with the genetic 
heterogeneity of T. whipplei (19), indicate that T. whipplei 
is a rather common gut bacterium.
We hypothesize that T. whipplei may cause gastro-
enteritis in children as a result of its primary contact with 
humans. In a preliminary study, we tested all patients with 
diarrhea at the University Hospitals in Marseille, France, 
and determined that this bacterium was found most often in 
children 2–4 years of age (26).
To investigate whether T. whipplei caused gastroen-
teritis, we studied the prevalence of T. whipplei DNA in 
a prospective study of children with diarrhea and controls 
with diarrhea. We genotyped T. whipplei to identify circu-
lating clones (9) and report overall ﬁ  ndings, including data 
from the preliminary study.
Materials and Methods
Patients
The study was reviewed and approved by the local 
ethics committee (agreement no. 07–006). A case-patient 
was deﬁ  ned as a child 2–4 years of age who had 2 positive 
quantitative PCR results speciﬁ  c for 2 T. whipplei DNA 
sequences, as reported (14,20). From January 2006 through 
December 2008, we tested 241 stool samples from 241 
children with diarrhea at 2 University Hospitals for chil-
dren in Marseille, France (Timone and Nord Hospitals) 
using a T. whipplei–speciﬁ  c PCR. Samples were obtained 
from all children in accordance with routine hospital proce-
dures. All stools samples were handled identically. Among 
36 children with gastroenteritis and T. whipplei DNA in 
stools, 11 stool specimens from 10 children were obtained 
after their recovery from diarrheal illness.
Five stool specimens were tested ≈15 days later, and 
6 were sampled ≈1 month later. Eight serum samples from 
children with gastroenteritis and positive PCR results for 
T. whipplei were tested retrospectively for T. whipplei by 
Western blot analysis. Data for patients with a deﬁ  nite di-
agnosis of Whipple disease and positive PCR results for T. 
whipplei PCR in stools at the time of diagnosis and data for 
adult asymptomatic carriers of T. whipplei in stools, which 
have been reported (14,20), were also included for quanti-
tative comparisons.
Controls
All T. whipplei–infected case-patients were compared 
with 67 gastroenteritis case-patients of the same age. These 
67 children had negative results for T. whipplei in stool 
specimens; epidemiologic, clinical, and biologic features 
were available for these children.
Forty-seven stool specimens from children 2–4 years 
of age without gastroenteritis were also tested for T. whip-
plei by using PCR. Twenty-ﬁ  ve children (11 girls and 14 
boys) were from kindergarten classrooms at the university 
hospitals. Samples were also obtained from 10 children (4 
boys and 6 girls) hospitalized at Timone Hospital for sur-
gery and from 12 children (5 boys and 7 girls) who visited 
the Emergency Department of Nord Hospital.
Twenty-ﬁ   ve serum samples obtained from children 
2–4 year of age with gastroenteritis and T. whipplei–nega-
tive results in stool specimens were tested retrospectively. 
Twenty control serum samples were obtained from 20 chil-
dren 1–36 months of age with a disease other than gastroen-
teritis. All serum samples were from children hospitalized 
in the 2 University Hospitals. These samples were obtained 
for routine management of these patients, not speciﬁ  cally 
for our study.
Diagnostic Procedures
Bacteria, viruses, and Giardia duodenalis were de-
tected by using standard methods. Stool specimens were 
plated onto Hektoen, Campylosel, and Yersinia cefsulo-
din–irgasan–novobiocin  agar plates (bioMérieux, Marcy 
L’Etoile, France). Plates selective for Campylobacter spp. 
were incubated under microaerophilic conditions; all other 
media and samples were incubated in ambient air. Temper-
ature of incubation was 37°C, with the exception of Yers-
inia agar, which was incubated at 30°C. Length of incuba-
tion was 5 days. For virus tests, stool specimens were tested 
by using a chromatographic immunoassay with a VIKIA 
Rota-Adeno Kit (bioMérieux) kit and electron microscopy 
with negative staining, which enabled detection of rota-
virus, adenovirus, calicivirus, astrovirus, Norwalk virus, 
coronavirus, and enterovirus. G. duodenalis was detected 
by PCR, as described (27).
T. whipplei quantitative PCR assays of stool samples 
were performed as reported (14,20,28). Approximately 1 
g of stool was obtained for DNA extraction by using the 
QIAamp DNA MiniKit (QIAGEN, Hilden, Germany), which 
was performed according to the manufacturer’s recommen-
dations. The ﬁ  rst T. whipplei–speciﬁ  c quantitative PCR 
speciﬁ  c for a 155-bp sequence used primer pair TW27 for-
ward (5′-TGTTTTGTACTGCTTGTAACAGGATCT-3′) 
and TW182 reverse (5′-TCCTGCTCTATCCCTCCTAT
CATC-3′) and a Taqman probe (27 forward–182 reverse, 
5′-6-FAM-AGAGATACATTTGTGTTAGTTGTTACA
-TAMRA-3′). The PCR was conducted in a LightCycler 
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(Roche Diagnostics, Meylan, France) (14,20,28) in a ﬁ  nal 
volume of 20 μL that contained 10 μL of the probe, master 
kit (QIAGEN), 0.5 μL (10 pmol/μL) of each primer, 5 μL 
(2 μmol/μL) of probe, 2 μL of distilled water, and 2 μL of 
extracted DNA. The ampliﬁ  cation conditions involved an 
initial denaturation step at 95°C for 15 min, followed by 40 
cycles of denaturation at 95°C for 15 s, and annealing and 
elongation at 60°C for 60 s, with ﬂ  uorescence acquisition 
in single mode. After every 5 samples, T. whipplei–neg-
ative controls (water, mixture, and human samples) were 
evaluated.
If the result of the ﬁ   rst PCR was positive, it was 
systematically conﬁ   rmed by a second PCR with a 
second set of primer pairs: TW13 forward (5′-TGA
GTGATGGTAGTCTGAGAGATATGT-3′) and TW163 
reverse (5′-TCCATAACAAAGACAACAACCAATC-3′). 
This second PCR used a Taqman probe (13 forward–163 
reverse, 5′-6-FAM-AGAAGAAGATGTTACGGGTTG-
TAMRA-3′) speciﬁ  c for a different 150-bp sequence, as 
described elsewhere; the same ampliﬁ  cation  conditions 
described above were used. For quantitative PCR, se-
quence-speciﬁ  c standard curves were generated by using 
10-fold serial dilutions of a standard concentration of 106 
microorganisms of the Marseille-Twist T. whipplei strain. 
The number of transcript copies in each sample was then 
calculated from the standard curve by using LightCycler 
software.
Genotyping of T. whipplei from stool specimens was 
performed as reported (19). This analysis was speciﬁ  c for 
4 highly variable genomic sequences (HVGS) and used 
primers TWT133 forward and reverse for HVGS 1, prim-
ers ProS forward and reverse for HVGS 2, primers SECA 
forward and reverse for HVGS 3, and primers TWT183 
forward and reverse for HVGS 4. PCR was performed 
in a PTC-200 automated thermal cycler (MJ Research, 
Waltham, MA, USA), as reported (19).
Serologic assays were performed by using Western 
blotting as described (29). Before blotting, protein concen-
tration was determined by using a commercial reagent (Bio-
Rad, Hercules, CA, USA). T. whipplei Twist proteins were 
resuspended in Laemmli buffer (Sigma-Aldrich Chimie, 
Saint Quentin Fallavier, France) containing 100 mmol/L 
dithiothreitol to obtain a ﬁ  nal protein concentration of 0.5 
μg/μL. The protein lysate was heated for 5 min at 100°C. 
Five micrograms of native protein was loaded into wells 
of a 7.5% polyacrylamide gel, and proteins were resolved 
by sodium dodecyl sufate–polyacrylamide gel electropho-
resis.
Proteins were then transferred to nitrocellulose mem-
branes (Transblot Transfer Medium, Pure Nitrocellulose 
Membrane, 0.45 mm; Bio-Rad) over a 2-hour period by us-
ing a semidry transfer unit (Hoeffer TE 77; GE Healthcare, 
Little Chalfont, UK). Membranes were immersed in phos-
phate-buffered saline supplemented with 0.2% Tween 20 
and 5% non-fat dry milk (blocking buffer) for 1 h at room 
temperature and incubated with primary serum (dilution 
1:1,000 in blocking buffer) for 1 h at room temperature. 
Membranes were then washed in triplicate with phosphate-
buffered saline–Tween 20, and immunoreactive spots were 
detected by incubating the membranes for 1 h at room tem-
perature with peroxidase-conjugated goat anti-human anti-
body (Southern Biotech, Birmingham, AL, USA) diluted 
1:1,000 in blocking buffer. The ﬁ  rst screening was per-
formed by testing for all immunoglobulins (Igs). Positive 
cases were then tested to separately detect IgG and IgM. 
Detection was performed by using chemiluminescence 
(Enhanced Chemiluminescence Western Blotting Analysis 
System; Amersham Biosciences, Uppsala, Sweden) with 
an automated ﬁ  lm processor (Hyperprocessor; GE Health-
care).
Statistical Analysis
Data were analyzed by using EpiInfo software version 
3.4.1 (Centers for Disease Control and Prevention, Atlanta, 
GA, USA). Proportions were compared by using the Yates 
χ2 corrected test or Fisher exact test. Continuous variables 
were compared by using analysis of variance or the Mann-
Whitney/Wilcoxon 2-sample test when data were not nor-
mally distributed. Signiﬁ  cance was deﬁ  ned as p<0.05.
Results
A total of 241 children 2–4 years of age with gastroen-
teritis were tested, and samples from 36 (15%) were posi-
tive for T. whipplei. In 2006, 2007, and 2008, the infec-
tion rates for T. whipplei were comparable: 12/78 (15.4%), 
10/72 (14%), and 14/91 (15.4%), respectively. No seasonal 
variation was observed. None of the children in the same 
age control group without diarrhea had samples positive for 
T. whipplei (0/47; p = 0.008). High bacterial loads (>104/g 
of stool) were observed in 64% (23/36) of the T. whipplei–
positive children. Such high loads have not been observed 
in chronic carriers, but they were comparable to the levels 
for patients with Whipple disease (14). Bacterial load in 
stools ranged from 170 to 1.5 × 106/g (mean ± SD 1.5 × 105 
± 3.6 × 105) for children with gastroenteritis versus 85 to 
2.5 × 106/g (mean ± SD 5.5 × 105 ± 8.3 × 105) for patients 
with Whipple disease (p = 0.1). Only 1 postdiarrheal stool 
specimen was slightly positive 15 days later and had a bac-
terial load <85/g of stool; the bacterial load was 2 × 104 at 
the time of diarrhea. Stool samples obtained from the same 
patient 1 month later were negative by PCR.
Genotyping of T. whipplei was performed for 34 chil-
dren with diarrhea. A dendogram showing phylogenetic or-
ganization of genotypes is shown in Figure 1. We observed 
genetic heterogeneity in sequences associated with gastro-
enteritis and identiﬁ  ed 12 new genotypes. One useful ﬁ  nd-
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ing was that genotype 3 was detected in 10 of the 34 chil-
dren. Using Western blotting, we found that case-patients 
with Whipple disease were signiﬁ  cantly more likely to be 
seropositive than controls with diarrhea (Figure 2) for IgG 
(7/8 vs. 5/25; p = 0.001) and IgM (7/8 vs. 1/25; p<0.001) 
and than controls without gastroenteritis for IgG (5/20; p = 
0.004) and IgM (1/20; p<0.001).
Clinical and biological features of the 36 PCR-pos-
itive children 2–4 years of age with diarrhea were com-
pared by retrospective review with those of matched 67 
control children of the same age who had gastroenteritis 
but were negative for T. whipplei by PCR. Results are 
summarized in Table 1. Among children with positive 
PCR results, the proportion of girls and boys was equal. T. 
whipplei PCR-positive patients with diarrhea had a milder 
illness than PCR-negative patients. Length of rehydration 
required, duration of fever, and duration of hospitaliza-
tion were signiﬁ  cantly shorter for the patients infected 
with T. whipplei (p = 0.003, p = 0.003, and p = 0.01, re-
spectively). Moreover, the level of C-reactive protein was 
signiﬁ   cantly lower incase-patients (p = 0.03). Patients 
with T. whipplei were less likely to experience anorexia 
(p = 0.03); however, their weight loss was signiﬁ  cant (p = 
0.045). Another signiﬁ  cant difference was increased con-
tact with sand boxes for case-patients (p = 0.002); how-
ever, the size of the group analyzed was small, and these 
data should be conﬁ  rmed.
Children infected with T. whipplei were co-infected 
with an associated pathogen more often than patients with 
diarrhea without T. whipplei infection (13/36 vs. 36/205; 
p = 0.01) (Table 2). Co-infection was less common in 23 
children with high T. whipplei bacterial loads (>104/g of 
stool) than in 13 children with lower bacterial loads (5/23 
vs. 8/13; p = 0.02).
Discussion
T. whipplei has been identiﬁ  ed by PCR in stools of per-
sons without Whipple disease (20). The source of T. whip-
plei is unknown, but data suggest that it the infection may 
result from fecal–oral or oral–oral transmission (2,20). T. 
whipplei is excreted in a live form by patients with Whipple 
disease (9), and T. whipplei DNA is found in stool samples 
of healthy persons (22). This bacterium is commonly found 
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Figure 1. Dendogram constructed by using unweighted pair group 
method with arithmetic mean and 4 highly variable genomic 
sequences (HVGS), showing phylogenetic diversity of 48 genotypes 
of 81 Tropheryma whipplei strains detected in 34 children with 
diarrhea (blue), 40 adult patients with Whipple disease (red), and 
22 asymptomatic adult patients without Whipple disease (green) 
(including 11 sewer workers), Marseille, France. Sequences were 
concatenated to construct the dendrogram. Numbers in parentheses 
indicate number of genotyped samples for each category. Stars, 
France; crosses, Switzerland; circles, Germany; diamond, Italy; 
square, Austria; triangle, Canada; small circle, Comoros. 
Figure 2. Western blot analysis of immunoglobulin (Ig) G and 
IgM against Tropheryma whipplei for children with gastroenteritis, 
Marseille, France. Total native antigens from T. whipplei were 
tested. A) Five patients without T. whipplei detected from stool 
samples but with positive Western blot serologic results. B) Eight 
patients infected with T. whipplei. MWM, molecular weight markers. 
Values on the right of each blot are in kilodaltons.RESEARCH
in sewers (20,23) and has also been detected in sewage 
(25). Therefore, it appears that T. whipplei is much more 
common than previously believed. A total of 3.8% (7/299) 
of adult controls in our study were PCR positive for T. 
whipplei (14). The bacterial load of T. whipplei in stools is 
much lower in asymptomatic carriers than in patients with 
Whipple disease (14,20).
We believe that our data provide strong evidence to 
support our initial hypothesis that T. whipplei causes mild 
gastroenteritis in children 2–4 years of age. All of our 
case-patients had 2 quantitative PCR-positive results, and 
genotyping of T. whipplei from 32 children enabled us to 
identify 12 new genotypes. Our data exclude the possibil-
ity of PCR contamination. We also found bacterial loads 
higher than those in previous reports of chronic carriers 
(20). However, these loads were comparable with those for 
patients with active Whipple disease (14). These high loads 
suggest that gastroenteritis in the children in our study was 
associated with active T. whipplei replication.
The absence of T. whipplei DNA in stools after patient 
recovery from diarrheal illness strongly suggests that de-
tection of T. whipplei DNA is associated with acute gastro-
enteritis rather than carriage, which is usually chronic (20). 
Moreover, 1 genotype (genotype 3) predominated, causing 
one third of the total number of cases.
Serologic analysis by Western blotting for T. whipplei 
(29) showed that all children who were PCR positive for 
T. whipplei had IgM against T. whipplei, which suggested 
that recent seroconversion had occurred. The prevalence 
of antibodies in case-patients was higher than that in con-
trols. Comparison of the prevalence of antibodies for con-
trol children (22%) with preliminary prevalence data for 
persons 61 ± 3.6 years of age (45%) (30) showed that the 
difference is signiﬁ  cant (p<0.001); thus, possible acquired 
immunity to infection with T. whipplei may explain why 
this bacterium causes diarrhea in children, but not in most 
adults.
We suspect that T. whipplei infection is contagious and 
transmitted by the fecal–oral route in children 2–4 years of 
age with other enteric pathogens. We previously reported 
an association between G. duodenalis infection and Whip-
ple disease (27). As with other organisms such as Helico-
bacter pylori, T. whipplei may also be transmitted through 
saliva because it has been found in saliva of asymptomatic 
carriers and patients with Whipple disease (20). Therefore, 
we hypothesized that primary infection with T. whipplei in 
780  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 16, No. 5, May 2010
Table 1. Clinical and biological characteristics and laboratory test results of children 2–4 years of age with gastroenteritis who tested 
positive by PCR for Tropheryma whipplei, compared with controls, Marseille, France* 
Characteristic T. whipplei PCR positive, n = 36  T. whipplei PCR negative, n = 67†  p value 
Male sex  19 (53)  35 (52)  0.9
Median age, mo  29 ± 6  29 ± 5  0.7
Sand box contact  4/4 (100)  0/8 (0)  0.002 
Anorexia  14 (39)  41 (62)  0.03
Weight loss, kg  0.9 ± 0.6  0.55 ± 0.35  0.045 
Vomiting 20 (55.5)  45 (67)  0.2
Abdominal pain  9 (25)  14 (21)  0.3
Dehydration  11 (30.5)  25 (37)  0.5
Watery diarrhea  25 (69)  46 (69)  0.9
Bloody diarrhea  3 (8)  5 (7.5)  0.9
Duration of diarrhea, d  4.5 ± 4  4.5 ± 4  0.9
No. stools/d  6 ± 3  5.5 ± 3  0.2
Length of rehydration required, h  19 ± 10  35 ± 23  0.003 
Fever, °C  38 ± 0.9  38.3 ± 1  0.2
Duration of fever, d  1.4 ± 1  3.6 ± 3.7  0.003 
Duration of hospitalization, d  1.6 ± 1.5  3.5 ± 3.8  0.01
Peripheral leukocyte count, × 10
9/L 10 ± 4  14 ± 7  0.2
Neutrophil count, × 10
9/L  6 ± 3  7.5 ± 6  0.7
Hemoglobin, g/dL  11.8 ± 1.5  11.9 ± 1.5  0.6
Fibrin, g/L  4 ± 0.8  4.2 ± 1.2  0.6
C-reactive protein, mg/mL  24 ± 23  64 ± 87  0.03
Serum albumin, g/L  37 ± 50.2  34 ± 3  0.2
Serum creatinine, mmol/L  37 ± 11  37 ± 12  0.99
Uremia, mmol/L  3.4 ± 2  3.4 ± 2  0.99
Proteinemia, g/L  69 ± 8  68.5 ± 7  0.7
Serum potassium, mmol/L  3.8 ± 0.5  3.9 ± 0.4  0.3
Partial thromboplastin time, s  31 ± 3  32 ± 5  0.6
Prothrombin time, s  83 ± 20  81 ± 17  0.7
*Values are no. (%), no. positive/no. tested (%), or mean ± SD.  
†Among 205 case-patients with gastroenteritis who were negative for T. whipplei, data were available for 67 patients. Tropheryma whipplei and Gastroenteritis
children may result in gastroenteritis, especially when as-
sociated with other intestinal pathogens. We have provided 
several lines of evidence that T. whipplei is causing or exac-
erbating gastroenteritis. The incidence of T. whipplei DNA 
in stools of children 2–4 years of age with gastroenteritis 
was higher than that in the control group; these infected 
children also have higher levels of antibodies. That healthy 
children of the same ages were not infected with T. whip-
plei also suggests that primary infection is symptomatic. 
Sociodemographic differences between the 2 groups could 
theoretically explain our ﬁ  ndings. However, most of our 
patients and controls were from the same geographic area, 
which enabled us to rule out this hypothesis.
We identiﬁ  ed 1 clone (genotype 3) in 10 children, 
which indicates that this clone is circulating in our popula-
tion. The association we found between T. whipplei and 
other pathogens transmitted by the fecal–oral route sup-
ports the conclusion that T. whipplei and other intestinal 
pathogens have a common source of infection and that they 
are often co-transmitted (31,32). However, for unknown 
reasons, T. whipplei could replicate in children with low-
grade chronic infections without causing diarrhea. That 
T. whipplei–infected patients were more likely to have 
co-infections than patients infected with other pathogens 
may also indicate that T. whipplei may decrease below mo-
lecular detection limits when diarrhea resolves. However, 
higher levels of IgM against T. whipplei in case-patients 
suggest infection with this bacterium. Moreover, an in vivo 
animal model of oral infection by T. whipplei has shown 
a pathogenic effect only in mice with previously inﬂ  amed 
colonic tissues (D. Raoult et al., unpub. data). Thus, in-
ﬂ  amed colonic tissues may also explain the frequency of 
co-infections with common pathogens observed in persons 
with T. whipplei–positive gastroenteritis.
We provide evidence that T. whipplei is commonly as-
sociated with gastroenteritis in children. We also suggest 
that other studies should be performed to evaluate the role 
of this bacterium and its prevalence in patients with gastro-
enteritis because it is present worldwide.
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